CD4 and Parkinson disease: It has been observed in the neurotoxic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD, that CD4+ T cells enter the substantia nigra and blocking or modulating that T cell response is neuroprotective [6, 46].